Estrogen antagonists and thrombosis prevention
Tilsner, V.
Deutsche Medizinische Wochenschrift 119(34-35): 1182
1994
ISSN/ISBN: 0012-0472 PMID: 8076509 Document Number: 431321
Document emailed within 1 workday
Related Documents
Lloyd, D.G.; Meegan, M.J. 2000: Recent advances in estrogen receptor antagonists Idrugs: the Investigational Drugs Journal 3(6): 632-642Dryzhak, V.I. 1989: Estrogen antagonists and inhibitors in hormone therapy of breast cancer Voprosy Onkologii 35(7): 771-778
Boeynaems, J.-M.; van Giezen, H.; Savi, P.; Herbert, J.-M. 2005: P2Y receptor antagonists in thrombosis Current Opinion in Investigational Drugs 6(3): 275-282
Stolley, P.D.; Tonascia, J.A.; Tockman, M.S.; Sartwell, P.E.; Rutledge, A.H.; Jacobs, M.P. 1975: Thrombosis with low-estrogen oral contraceptives American Journal of Epidemiology 102(3): 197-208
Smith, P. 1995: Estrogen and thrombosis--additional research still needed Lakartidningen 92(42): 3869-3870
Lussana, F.; Faioni, E.M.; Mavilia, C.; Bucciarelli, P.; Brandi, M.Luisa.; Cattaneo, M. 2006: Association of estrogen receptor-alpha genepolymorphisms with venous thrombosis Haematologica 91(2): 279-280
Carl, P. 1985: Recurrent thrombosis of the subclavian vein during estrogen therapy of prostatic cancer Deutsche Medizinische Wochenschrift 110(4): 155
Rockel, P.; Hoffmann, B.; Kyrein, H.J. 1978: Relationships between the size of ovarian follicles, the binding capacity of uterine estrogen receptors and estrogen concentrations in the follicular fluid and urine of calves under estrogen therapy Berliner und Munchener Tierarztliche Wochenschrift 91(24): 476-479
Lee, J.A.; Watson, L.A.; Boothby, G. 1986: Calcium antagonists in the prevention of motion sickness Aviation Space and Environmental Medicine 57(1): 45-48
Blankenstein, M.A.; Mulder, E.; Broerse, J.J.; Van Der Molen, H.J. 1980: Mammary gland estrogen receptors and plasma prolactin during estrogen enhanced rat mammary tumor development strain difference in the response to estrogen Radiation and Environmental Biophysics 17(4): 359
Modena, M.G.; Origliani, G.; Rossi, R. 2000: Use of estrogen-progestins in secondary prevention Italian Heart Journal. Supplement: Official Journal of the Italian Federation of Cardiology 1(3): 435-436
Pikto-Pietkiewicz, W. 2006: Adrenergic beta-Antagonists in prevention of cardiovascular complications in major non-cardiac surgery Kardiologia Polska 64(9): 1028-1030
Ciaco, A.; Papi, C.; Capurso, L. 1992: Sulglycotide combined with H2-antagonists in the prevention of duodenal ulcer recurrence. Multicenter study Minerva Gastroenterologica e Dietologica 38(3): 153-159
Rachev, E.; Katsarova, M.; Trepechov, S. 1989: Estrogen-gestagen prevention and treatment of uterine hemorrhages in the premenopause Akusherstvo i Ginekologiia 28(3): 78-81
Yonekura, S.; Okamoto, Y.; Okubo, K.; Okawa, T.; Gotoh, M.; Suzuki, H.; Kakuma, T.; Horiguchi, S.; Hanazawa, T.; Konno, A.; Okuda, M. 2009: Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting Journal of Investigational Allergology and Clinical Immunology 19(3): 195-203
Lindsay, R.; Hart, D.M.; Clark, D.M. 1984: The minimum effective dose of estrogen for prevention of postmenopausal bone loss Obstetrics and Gynecology 63(6): 759-763
Elder, C.A.; Restino, M.S. 1992: Beta-adrenergic antagonists for primary prevention of gastrointestinal hemorrhage in patients with cirrhosis and esophageal varices Clinical Pharmacy 11(4): 337-341
Lundh, B.; Fagher, B. 1980: Treatment of thrombosis and prevention of recurrence Lakartidningen 77(23): 2186-2189
Riedler, G.F. 1977: Prevention of thrombosis in internal medicine Therapeutische Umschau. Revue Therapeutique 34(5): 363-367
Søballe, K.; Christensen, F.; Jønsson, B. 1987: Prevention of thrombosis with vitamin K after hip arthroplasty Ugeskrift for Laeger 149(28): 1877-1879